Using modified antigenic sequences to develop cancer vaccines: are we losing the focus?
Valmori
Danila
D
Ludwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, New York, USA. dv2117@columbia.edu
Ayyoub
Maha
M
D000951:Antigens, Neoplasm / Q000276:immunology*; D019496:Cancer Vaccines / Q000276:immunology*; D006801:Humans; D008285:Major Histocompatibility Complex / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines